Acute Myocardial InfarctionNCT03032289
Association Between Active Transport and Acute Myocardial Infarction
An observational study of Acute Myocardial Infarction, run by University of Leeds at 1 site in United Kingdom.
Trial summary
This study aims to investigate the association between active transport and the incidence of acute myocardial infarction in England. Read more about this study
- Who is it for?
- Ages 16 to 64 years
- Conditions the study is for
- Acute Myocardial Infarction
- What is being tested?
- Active Transport
- Type of treatment
- Lifestyle or therapy programme
- How many people
- 100,482 participants
- Where
- 1 siteUnited Kingdom
- Study dates
- 1 Jan 2010to 31 Dec 2013
- How long will I take part?
- 3 Years
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 16 to 64 years
- All sexes
- Child, Adult
Study population: All cases of acute myocardial infarction recorded in the Myocardial Ischaemia National Audit Project (MINAP).
Who may be able to join
- All cases of acute myocardial infarction recorded in MINAP between 2003 and 2010
Who cannot join
- Cases aged <16 and >64 years
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Association Between Active Transport and Acute Myocardial Infarction: Cross Sectional Ecological Study Using National Registry and Census Data
This study aims to investigate the association between active transport and the incidence of acute myocardial infarction in England.
Read the detailed description
This is a cross sectional ecological study using aggregated data from the existing Myocardial Ischaemia National Audit Project between 2010 and 2013. Data on active transport according to local authority was obtained from the UK 2001 and 2011 census, whilst important confounders including deprivation levels, prevalence of obesity and population smoking estimates were obtained from Public Health England.
In addition to investigating the association between active transport and AMI, we also studied the extent to which the components of active transport, cycling and walking, were associated with AMI, and investigated whether any associations were contingent on a time lag effect between the dates of exposure to active transport and indecent AMI.
- Conditions
- Acute Myocardial Infarction
- Being tested
- Active Transport
- Keywords
- active transport, cycling, walking
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Active TransportBehavioural
Active transport, most commonly walking or cycling, is the use of physical activity to commute.
What is being measured
The primary outcome is the main question the study is designed to answer.
Acute myocardial infarction
Admissions for acute myocardial infarction as recorded in MINAP
Measured: 2010 to 2013
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted26 Jan 2017 (estimated)
- Study start1 Jan 2010
- Primary completion31 Dec 2013
- Study completion31 Dec 2013
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Acute Myocardial InfarctionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Ecologic or community
- Time perspective
- Cross-sectional
- Enrolment
- 100,482 participants (actual)
- Target duration
- 3 Years
Sponsor and investigators
- Lead sponsor
- University of Leeds
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Marlous Hall, University of Leeds
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03032289
- Sponsor's protocol ID
- UoL_MINAP_Cycling
- Status last verified
- Jan 2017
- First submitted
- 24 Jan 2017
- Last updated
- 26 Jan 2017
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 26 Jan 2017. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Association Between Active Transport and Acute Myocardial Infarction: Cross Sectional Ecological Study Using National Registry and Census Data
- ClinicalTrials.gov ID
- NCT03032289
- Acronym / sponsor ID
- UoL_MINAP_Cycling
- Conditions
- Acute Myocardial Infarction
- Keywords
- active transport, cycling, walking
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 100,482 participants (actual)
- Lead sponsor
- University of LeedsUniversity, hospital or other
- Study start
- 1 Jan 2010 (actual)
- Primary completion
- 31 Dec 2013 (actual)
- Study completion
- 31 Dec 2013 (actual)
- First posted
- 26 Jan 2017 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aims to investigate the association between active transport and the incidence of acute myocardial infarction in England.
Detailed description
This is a cross sectional ecological study using aggregated data from the existing Myocardial Ischaemia National Audit Project between 2010 and 2013. Data on active transport according to local authority was obtained from the UK 2001 and 2011 census, whilst important confounders including deprivation levels, prevalence of obesity and population smoking estimates were obtained from Public Health England.
In addition to investigating the association between active transport and AMI, we also studied the extent to which the components of active transport, cycling and walking, were associated with AMI, and investigated whether any associations were contingent on a time lag effect between the dates of exposure to active transport and indecent AMI.
Study design
- Observational model
- Ecologic or community
- Time perspective
- Cross-sectional
- Target follow-up
- 3 Years
Who may qualify
- Ages
- 16 to 64 years
- Sex
- All
- Age groups
- Child, Adult
- Study population
- All cases of acute myocardial infarction recorded in the Myocardial Ischaemia National Audit Project (MINAP).
Key inclusion criteria (1 listed)
- All cases of acute myocardial infarction recorded in MINAP between 2003 and 2010
Key exclusion criteria (1 listed)
- Cases aged <16 and >64 years
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Active TransportActive transport, most commonly walking or cycling, is the use of physical activity to commute. | Behavioural | – |
Primary outcome
Acute myocardial infarction
Time frame: 2010 to 2013
Admissions for acute myocardial infarction as recorded in MINAP
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 26 Jan 2017.
Related trials for Acute Myocardial Infarction
RecruitingObservational study
Changes in Skeletal Muscle Thickness in Patients With Acute Heart Failure
Heart Failure, Muscle Atrophy
Recruiting
Routine Versus Provisional Distal Perfusion Catheter Placement in Patients Undergoing Mechanical Circulatory Support
Cardiogenic Shock, Acute Myocardial Infarction of Inferior Wall
Recruiting
Ezetimibe Utilization Early After Acute Myocardial Infarction, "EzAMI Trial"
Acute Myocardial Infarction, Dyslipidemias
Not yet recruitingObservational study
iLITE, Clinical Performance of the Angiolite™ Drug-Eluting Stent
PCI Patients, de Novo Coronary Lesions
Active, not recruiting
Point-of-Care Troponin Testing in the Emergency Department
Acute Coronary Syndromes
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Acute Myocardial Infarction, run by University of Leeds at 1 site in United Kingdom.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 26 Jan 2017. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Acute myocardial infarction (time frame: 2010 to 2013). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Jan 2017.